IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enavate Sciences GP, LLC

Portfolio Profile

CIK: 0001953107 | New York, NY

Investment Profile

Style

Deep Value

Turnover

Very Low

Orientation

Concentrated long-term
$345.4M
AUM
7
Positions
100%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Sionna Therapeutics Inc(SION)2,478,030$109.0M31.56%
2Zenas Biopharma Inc(ZBIO)3,919,159$99.5M28.80%
3Immunome Inc(IMNM)3,613,799$76.6M22.17%
4Bridgebio Oncology Therapeut(BBOT)2,626,946$20.0M5.80%
5Compass Therapeutics Inc(CMPX)7,788,150$17.1M4.94%

Sector Allocation

Latest filing, equity positions only

Healthcare100% · $345.4M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare100%100%0%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %Change
Small Cap74.77%

AUM History

$139.2M | 5 pos.
$132.7M | 6 pos.
$176.5M | 6 pos.
$327.5M | 7 pos.
$506.8M | 7 pos.
$351.5M | 7 pos.
6
Upstream BIO Inc(UPB)
2,459,703
$17.0M
4.93%
7Camp4 Therapeutics Corp(CAMP)1,425,541$6.2M1.80%
76.02%
+1.25%
Mid Cap22.48%22.17%-0.31%
Micro Cap2.75%1.8%-0.95%
$345.4M | 7 pos.
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

0
New
0
Closed
0
Increased
1
Decreased
6
Unchanged